Research - Heidelberg, Baden-Württemberg, Germany
Combining our expertise and experience of more than 28 years in Biotechnology, Biopharm is devoted to discover innovative substances and technologies in regenerative medicine. Biopharm's unique Growth Factor Technology Platform enables new advanced applications using its tailor-made drug design providing significant benefits over existing growth factors currently available on the market. The experienced staff at Biopharm has accumulated extensive projects in several areas: · Wound healing (preclinical) · Osteoporosis (preclinical) · Maxillo-facial (licensed to Scil Technology/Phase III) · Degenerative disc disease (Phase II) · Fracture healing (preclinical) · Parkinson disease (preclinical) · Prostatectomy after effect (preclinical) · Osteoarthrisis (partnership with Merck Serono/preclinical)